NYSE:BDX

Becton Dickinson stock jumps 5% as BDX rebounds from forecast reset

Becton, Dickinson and Company shares jumped 5.2% to $180.62 in after-hours trading Wednesday after cutting its 2026 adjusted earnings forecast following the Waters deal. First-quarter revenue reached $5.25 billion, with adjusted EPS at $2.91. Trading volume nearly tripled its 50-day average. Investors remain focused on margins amid China pricing pressure, tariffs, and the Alaris pump cycle.

11 February 2026

NYSE:BDX·Stock Market

BD Stock Slides After Waters Deal Closes: Why BDX’s 2026 Profit View Changed

Becton, Dickinson and Company shares fell 1.2% to $207.39 in after-hours trading after it cut its 2026 profit outlook following the spin-off of its Biosciences & Diagnostic Solutions unit to Waters. BD shareholders received 0.135 Waters shares per BD share. The new 2026 adjusted EPS forecast of $12.35–$12.65 is well below prior guidance and Wall Street estimates. Waters shares dropped 14%.

9 February 2026

NYSE:BDX·NYSE:WAT·Stock Market

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Dow futures rose 46 points premarket Monday, while S&P 500 and Nasdaq 100 futures slipped ahead of Wednesday’s delayed January jobs report and Friday’s CPI. Hims & Hers shares fell 14.8% premarket after scrapping plans for a $49 weight-loss pill; Novo Nordisk jumped over 8% in Copenhagen. Treasury buyback details and Fed speeches are due later today.

9 February 2026

Federal Reserve·NYSE:APO·NYSE:BDX·NYSE:KD·NYSE:L·Stock Market

Shocking CFO Departure Sends BDX Stock Tumbling — But Growth Remains Strong

BD said CFO Chris DelOrefice will step down Dec. 5, 2025, with Vitor Roque named interim CFO. Preliminary Q4 revenue rose 8.3% to $5.9 billion, but shares fell 5.8% after hours as U.S. regulators opened a medical-device import probe. FY2025 adjusted EPS is expected at or above guidance midpoint. Analysts’ consensus price target is $205–217.

16 October 2025

NYSE:BDX